HealthFinancing
Orexo AB (publ) proposes SEK250M rights issue ahead of drug milestones
Orexo expects to announce final issue terms preliminarily on Nov. 3 and plans a shareholder vote for Nov. 6.
Section
Financing
Every story filed under Financing, newest first.
Health
TSE: SVASeraxis notes are expected to convert into BetaNova stock if the merger closes; the first SR-02 patient dose is targeted for Q1 2027.
Health
NASDAQ: SMMTA signed trial pact covers ivonescimab and sonesitatug vedotin in gastrointestinal cancers; Summit expects the share sale to close by Oct. 2.
Latest
Humble & Fume forms joint venture, expands cannabis distribution to California
Humble & Fume invested US$8 million into the joint venture, with Green Acre Capital Distribution Corp. making a US$2 million investment
Curaleaf to raise US$425M from private placement
The firm says the low interest rate will allow it to refinance its debt
Average deal size cut in half by Covid: Canopy Rivers CEO Q&A
Narbé Alexandrian speaks on his firm's approach to deal-making, why software has become more attractive and the future consolidation of cannabis retail
BC's weed business guide centralizes key info but does little to dismantle barriers to entry
With Premier Horgan's stated goal of restoring 'legendary' status to provincial product, there should be more money where his mouth is
Psychedelics are experiencing a renaissance, but don't expect them to be legalized anytime soon
Research, therapeutic and medical drug development and investment can all flourish under pre-existing legal pathways, experts say
Weed companies eligible for federal relief funds, but there's a catch
Businesses have to apply through a bank, many of which still refuse to work with cannabis
‘Guys, we have one job: survive’
Analysis: Business professor says weed companies have to make tough decisions to survive the oncoming recession, as his did in the dot-com era
Execs shouldn’t get big payouts until companies are cash flow positive: Ryerson prof
Massive bonuses and mansions drew the ire of shareholders in MedMen, which demoted its CEO on Friday
Cannabis lawyer forecasts slew of bankruptcies in 2020
Developed brands and cash flow will separate the winners from the losers over the next 12 months
Hexo drops on share offering, inventory writedown
The Quebec-based producer diluted the value of its existing stock by issuing more shares as it also reported a $2.4 million write-down on 'cannabis trim'
TGOD expands Canaccord financing deal
The company says it will use the proceeds to finish building its Ancaster, Ont., processing facility
Aphria gets $80 million secured loan at 5% interest rate
Interim CEO says his company has the largest non-diluted cash balance in the cannabis industry